Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation

被引:0
|
作者
Asleh, R. [1 ]
Briasoulis, A. [2 ]
Smith, B. [1 ]
Lopez, C. [1 ]
Lerman, A. [1 ]
Pereira, N. L. [1 ]
Daly, R. C. [1 ]
Kremers, W. K. [1 ]
Clavell, A. L. [1 ]
Stulak, J. M. [1 ]
Kushwaha, S. S. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
[2] Univ Iowa Hosp & Clin, Div Cardiovasc Dis, Iowa City, IA 52242 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
164
引用
收藏
页码:S76 / S76
页数:1
相关论文
共 50 条
  • [1] Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation
    Asleh, Rabea
    Briasoulis, Alexandros
    Smith, Byron
    Lopez, Camden
    Alnsasra, Hilmi
    Pereira, Naveen L.
    Edwards, Brooks S.
    Clavell, Alfredo L.
    Stulak, John M.
    Locker, Chaim
    Kremers, Walter K.
    Daly, Richard C.
    Lerman, Amir
    Kushwaha, Sudhir S.
    [J]. JOURNAL OF CARDIAC FAILURE, 2021, 27 (05) : 542 - 551
  • [2] LONG-TERM EFFECTS OF ASPIRIN ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND ADVERSE OUTCOMES AFTER HEART TRANSPLANTATION
    Asleh, Rabea
    Briasoulis, Alexandros
    Lerman, Amir
    Smith, Byron
    Lopez, Camden
    Pereira, Naveen
    Edwards, Brooks
    Stulak, John
    Kremers, Walter
    Clavell, Alfredo
    Daly, Richard
    Kushwaha, Sudhir
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1074 - 1074
  • [3] Incidence, progression and functional significance of cardiac allograft vasculopathy after heart transplantation
    Julius, BK
    Jost, CHA
    Sütsch, G
    Brunner, HP
    Kuenzli, A
    Vogt, PR
    Turina, M
    Hess, OM
    Kiowski, W
    [J]. TRANSPLANTATION, 2000, 69 (05) : 847 - 853
  • [4] Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation
    Bergmark, Brian A.
    Zelniker, Thomas A.
    Kim, Miae
    Mehra, Mandeep R.
    Stewart, Garrick C.
    Page, Deborah S.
    Woodcome, Erica L.
    Givertz, Michael M.
    [J]. CLINICAL TRANSPLANTATION, 2021, 35 (10)
  • [5] DYSLIPIDEMIA AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Simonenko, M.
    Sazonova, Y.
    Fedotov, P.
    Krasnov, V.
    Rubinchik, V.
    Pervunina, T.
    Berezina, A.
    Privorotskii, V.
    Zverev, D.
    Sitnikova, M.
    Nikolaev, G.
    Gordeev, M.
    Karpenko, M.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 11 - 11
  • [6] OBESITY AND CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
    Carr, S.
    Hamilton, M.
    Kobashigawa, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 158 - 158
  • [7] DIFFERENTIAL EFFECTS OF SIROLIMUS-AND CALCINEURIN INHIBITOR-ASSOCIATED HYPERLIPIDEMIA ON CARDIAC ALLOGRAFT VASCULOPATHY PROGRESSION AND OUTCOMES AFTER HEART TRANSPLANTATION
    Asleh, Rabea
    Briasoulis, Alexandros
    Pereira, Naveen
    Edwards, Brooks
    Clavell, Alfredo
    Boilson, Barry
    Frantz, Robert
    Schirger, John
    Rodeheffer, Richard
    Maltais, Simon
    Stulak, John
    Daly, Richard
    Lerman, Amir
    Kushwaha, Sudhir
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 670 - 670
  • [8] Accelerated cardiac allograft vasculopathy after pediatric heart transplantation
    Zablah, Jenny E.
    Everitt, Melanie D.
    Wilson, Neil
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (11) : 2984 - 2985
  • [9] Cardiac allograft vasculopathy after heart transplantation: Is it really ominous?
    Lim, Ju Yong
    Jung, Sung Ho
    Kim, Min Seok
    Park, Jeong-Jun
    Yun, Tae-Jin
    Kim, Jae Joong
    Lee, Jae Won
    [J]. CLINICAL TRANSPLANTATION, 2017, 31 (02)
  • [10] PET Assessment of Cardiac Allograft Vasculopathy After Heart Transplantation
    Asleh, Rabea
    Kushwaha, Sudhir S.
    [J]. JACC-HEART FAILURE, 2023, 11 (05) : 566 - 568